Targeting MALT1 in B-cell Lymphomas

Safimaltib, a selective allosteric MALT1 protease inhibitor, shows potent antitumor activity in preclinical and clinical studies of B-cell non-Hodgkin lymphomas. See related article by Philippar et al., p. XX See related article by Hertzberg et al., p. XX.

Authors

Institutions

Publication Details

Journal
Blood Cancer Discovery
Published
2026-10-30
DOI
https://doi.org/10.1158/2643-3230.bcd-26-0324
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Targeting MALT1 in B-cell Lymphomas

Kojo S.J. Elenitoba‐Johnson, Huan-Chang Liang
2 links
Blood Cancer Discovery
Lymphoma Diagnosis and Treatment
article

Targeting MALT1 in B-cell Lymphomas

Kojo S.J. Elenitoba‐Johnson, Huan-Chang Liang
article en

Abstract

Safimaltib, a selective allosteric MALT1 protease inhibitor, shows potent antitumor activity in preclinical and clinical studies of B-cell non-Hodgkin lymphomas. See related article by Philippar et al., p. XX See related article by Hertzberg et al., p. XX.

Blood Cancer Discovery
Memorial Sloan Kettering Cancer Center (US)
Good health and well-being
Openalex Percentile: Top 12%
Lymphoma Diagnosis and Treatment
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Targeting MALT1 in B-cell Lymphomas — Kojo S.J. Elenitoba‐Johnson, Huan-Chang Liang · Blood Cancer Discovery (2026) | TGRS Research Map | TGRS